As of 6 Nov 2026, Starsource Multitrade is loss-making on a trailing 12-month basis, with a net loss of ₹0.03 Cr, so it has no P/E ratio. The share price is ₹118.00, 23% below its 52-week high. It is a small-cap company with a market cap of ₹18 Cr, ranked 18th of 20 Biotechnology companies by market cap; the shares fell 5.8% over the past year.
- ₹119.00
- ₹119.00
- ₹117.00
- ₹116.00
- 53
Health check
- ReturnsIn line
−5.8% over a year, better than 3 of 7 peers.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- Growthn/a
Not enough yearly results to measure.
- ProfitabilityNegative
ROCE -914.7% vs peer median 16.7%.
- Balance sheetn/a
Balance sheet figures aren’t reported.
- Red flags3 to check
Loss-making over the last twelve months.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹18 Cr
- Small cap
- P/E
- n/a
- Industry 49.1
- Price to book
- 13.72
- Peers 4.68
- Dividend yield
- 0.00%
- ROE
- −164.3%
- Peers 14.3%
- ROCE
- −914.7%
- Peers 16.7%
- Debt to equity
- n/a
- Debt ₹0.00 Cr
- EPS (TTM)
- −₹0.27
- OPM (TTM)
- 28.2%
- Net margin −4.8%
- Sales growth
- +260.1%
- Latest quarter vs a year ago
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 29.33
- EV/EBITDA −603.3
Strengths and risks
Strengths
- Quarterly sales up 260.1% on a year ago.
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at −164.3%.
- Interest coverage of only −5.1×.
About Starsource Multitrade
Starsource Multitrade Limited engages in the commodity trading business in India. It is also involved in bulk and wholesale trading of goods; agro and agro related products trading; and scrap trading, as well as contractual work related to railway. The company was formerly known as Chemo Pharma Laboratories Limited and changed its name to Starsource Multitrade Limited in October 2025. Starsource Multitrade Limited was incorporated in 1942 and is based in…
- Headquarters
- Ahmedabad
- Sector
- Healthcare
- ISIN
- INE320M01019
- Website
- starsourcemultitrade.com
Price range
- Avg volume (3M)
- 473
- 1-year return
- minus 5.8%
- From 52-week high
- minus 22.8%
Peers · Biotechnology
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOCONBiocon | 365.10 | plus 0.86% | 59,794 | 122.5 | 1.73 | 2.8% | 1.0% | 19.4% | 15.3% | −5.9% | 0.14% | minus 4.9% |
| ANTHEMAnthem Biosciences | 915.55 | plus 0.22% | 51,594 | 84.6 | 15.74 | 26.8% | 20.4% | 41.4% | 26.2% | 15.4% | 0.22% | plus 30.1% |
| ONESOURCEOnesource Specialty Pharma | 1,599.80 | plus 1.13% | 18,346 | – | 3.10 | 0.3% | 0.0% | 23.5% | 232.3% | – | 0.00% | minus 13.7% |
| CONCORDBIOConcord Biotech | 632.60 | minus 5.96% | 13,236 | 47.4 | 6.48 | 16.7% | 14.3% | 34.5% | 8.0% | 2.8% | 0.60% | minus 7.5% |
| BLUEJETBlue Jet Healthcare | 553.80 | minus 3.91% | 9,607 | 34.5 | 4.52 | 24.0% | 19.9% | 31.4% | 9.4% | 15.7% | 0.22% | minus 5.0% |
| SUPRIYASupriya Lifescience | 695.80 | minus 19.99% | 5,600 | 28.2 | 4.68 | 22.3% | 19.1% | 21.4% | 21.2% | 32.5% | 0.14% | plus 9.2% |
| ZOTAZota Health Care | 1,231.10 | plus 1.01% | 4,264 | – | 6.82 | −7.3% | −24.1% | 0.1% | 56.7% | – | 0.08% | minus 21.9% |
| STARSOURCEStarsource Multitrade | 118.00 | plus 1.72% | 18 | – | 13.72 | −914.7% | −164.3% | 28.2% | – | – | 0.00% | minus 5.8% |
| Median of 7 peers | – | 0.22% | 13,236 | 47.4 | 4.68 | 16.7% | 14.3% | 23.5% | 21.2% | 15.4% | 0.14% | −5.0% |
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| – | 0.5 | – | – | 0.1 | |
| – | 0.4 | – | – | 0.1 | |
| −11.8 | 0.1 | −0.1 | −0.1 | 0 | |
| – | 18.7% | – | – | 28.4% | |
| 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | – | – | 0 | |
| – | – | – | 0 | 0 | |
| −11.8 | 0.1 | −0.1 | −0.1 | 0 | |
| – | – | – | −0.1% | – | |
| −11.8 | 0.1 | −0.1 | −0.1 | 0 | |
| -78.70 | 0.65 | -0.58 | -0.48 | 0.14 |
Profit & loss
- ROE
- −164.3%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| – | – | – | 0.5 | |
| – | – | – | 0.5 | |
| −0.2 | −0.2 | −0.1 | −0 | |
| – | – | – | −1.0% | |
| 0.7 | 0.8 | 0.6 | 0 | |
| 0 | 0 | – | 0 | |
| 0 | 0 | 0 | 0 | |
| −0.4 | 1 | 0.1 | −11.9 | |
| 0.1 | 1.6 | 0.5 | −11.9 | |
| 35.4% | 27.0% | 31.3% | 0.0% | |
| 0 | 1.2 | 0.3 | −11.9 | |
| – | +2437.6% | minus 71.5% | minus 3564.2% | |
| 0.32 | 8.00 | 2.28 | -79.03 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 1.5 | 1.5 | 1.5 | 1.5 | |
| 10.1 | 11.3 | 11.6 | −0.2 | |
| 0 | 0.2 | 0.2 | 0.5 | |
| 11.6 | 13 | 13.3 | 1.8 | |
| 0 | 0 | 0 | 0 | |
| 3 | 4.4 | 0 | 0 | |
| 6.1 | 6.1 | 10.6 | 0 | |
| 2.5 | 2.5 | 2.7 | 1.8 | |
| 11.6 | 13 | 13.3 | 1.8 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| −0.7 | 0.7 | −0.3 | −10.6 | |
| 0.6 | −0.5 | 10.5 | 0 | |
| −0.1 | −0.1 | −0.2 | – | |
| −0.1 | 0 | 10 | −10.6 | |
| −0.7 | 0.7 | −0.3 | −10.6 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.